Chronic kidney disease and dipstick proteinuria are risk factors for stent thrombosis in patients with myocardial infarction

American Heart Journal

Volumn 157, Issue 4, 2009, Pages 688-694

  Lambert, Nathan D ^a   Sacrinty, Matthew T ^a   Ketch, Terry R ^a   Turner, Samuel J ^a   Santos, Renato M ^a   Daniel, Kurt R ^a   Applegate, Robert J ^a   Kutcher, Michael A ^a   Sane, David C ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIAC PATIENT; CHRONIC KIDNEY DISEASE; CORONARY ARTERY BYPASS GRAFT; CORONARY STENT; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; RETROSPECTIVE STUDY; REVASCULARIZATION; STENT THROMBOSIS;

AGED; CAUSE OF DEATH; CORONARY RESTENOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; NORTH CAROLINA; PROGNOSIS; PROTEINURIA; RETROSPECTIVE STUDIES; RISK FACTORS; STENTS; URINALYSIS;

EID: 62949115968     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2009.01.009     Document Type: Article

References (30)

1. Anderson J.L., Adams C.D., Antman E.M., et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction. J Am Coll Cardiol 50 (2007) e1-e157
2. Mauri L., Hsieh W., Massaro J.M., et al. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 356 (2007) 1020-1029
3. Iakovou I., Schmidt T., Bonizzoni E., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005) 2126-2130
4. de la Torre-Hernandez J.M., Alfonso F., Hernandez F., et al. Drug-eluting stent thrombosis. Results from the multicenter Spanish registry ESTROFA. J Am Coll Cardiol 51 (2008) 986-990
5. Park D.W., Park S.W., Park K.H., et al. Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up. Am J Cardiol 98 (2006) 352-356
6. Bavry A.A., and Bhatt D.L. Appropriate use of drug-eluting stents: balancing the reduction in restenosis with the concern of late thrombosis. Lancet 371 (2008) 2134-2143
7. Ong A.T., McFadden E.P., Regar E., et al. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 45 (2005) 2088-2092
8. Cutlip D.E., Baim D.S., Ho K.K., et al. Stent thrombosis in the modern era; a pooled analysis of multicenter coronary stent clinical trials. Circulation 103 (2001) 1967-1971
9. Coresh J., Selvin E., Stevens L.A., et al. Prevalence of chronic kidney disease in the United States. JAMA 298 (2007) 2038-2047
10. Go A.S., Chertow G.M., Fan D., et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351 (2004) 1296-1305
11. Manjunath G., Tighiouart H., Ibrahim H., et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol 41 (2003) 47-55
12. Mann J.F., Gerstein H.C., Pogue J., et al. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 134 (2001) 629-636
13. Fried L.P., Kronmal R.A., Newman A.B., et al. Risk factors for 5-year mortality in older adults. JAMA 279 (1998) 585-592
14. Anavekar N.S., McMurray J.J., Velazquez E.J., et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351 (2004) 1285-1295
15. Sarnak M.J., Levey A.S., Schoolwerth A.C., et al. Kidney disease as a risk factor for development of cardiovascular disease. Circulation 108 (2003) 2154-2169
16. Barratt J., and Topham P. Urine proteomics: the present and future of measuring urinary protein components in disease. CMAJ 177 (2007) 361-368
17. Levey A.S., Greene T., Kusek J.W., et al. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 11 (2000) 155A
18. Applegate R.J., Sacrinty M.T., Kutcher M.A., et al. "Off-label" stent therapy 2-year comparison of drug-eluting versus bare-metal stents. J Am Coll Cardiol 51 (2008) 607-614
19. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39 2 suppl 1 (2002) S1-S266
20. Cutlip D.E., Windecker S., Mehran R., et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115 (2007) 2344-2351
21. McCullough P.A. Why is chronic kidney disease the "spoiler" for cardiovascular outcomes?. J Am Coll Cardiol 41 (2003) 725-728
22. Pontremoli R., Sofia A., Ravera M., et al. Prevalence and clinical correlates of microalbuminuria in essential hypertension: the MAGIC study. Hypertension 30 (1997) 1135-1143
23. Dell'Omo G., Penno G., Giorgi D., et al. Association between high-normal albuminuria and risk factors for cardiovascular and renal disease in essential hypertensive men. Am J Kidney Dis 40 (2002) 1-8
24. Hillege H.L., Janssen W.M., Bak A.A., et al. Microalbuminuria is common, also in a nondiabetic nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular mortality. J Intern Med 249 (2001) 519-526
25. Ratto E., Leoncini G., Viazzi F., et al. Inappropriate left ventricular mass is associated with microalbuminuria independently of left ventricular hypertrophy in primary hypertension. J Hypertens 26 (2008) 345-350
26. Liu J.E., Robbins D.C., Palmieri V., et al. Association of albuminuria with systolic and diastolic left ventricular dysfunction in type 2 diabetes. The Strong Heart Study. J Am Coll Cardiol 41 (2003) 2022-2028
27. Birn H., and Christensen E. Renal albumin absorption in physiology and pathology. Kidney Int 69 (2006) 440-449
28. Zoja C., Donadelli R., Colleoni S., et al. Protein overload stimulates RANTES production by proximal tubular cells depending on NF-kappa B activation. Kidney Int 53 (1998) 1608-1615
29. Tang S., Leung J.C., Abe K., et al. Albumin stimulates interleukin-8 expression in proximal tubular epithelial cells in vitro and in vivo. J Clin Invest 111 (2003) 515-527
30. Tonelli M., Jose P., Curhan G., et al. Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trial. BMJ 332 (2006) 1426-1429